Correlation Between Novo Nordisk and CSL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and CSL LTD SPONADR, you can compare the effects of market volatilities on Novo Nordisk and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and CSL.

Diversification Opportunities for Novo Nordisk and CSL

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Novo and CSL is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and CSL LTD SPONADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL LTD SPONADR and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL LTD SPONADR has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and CSL go up and down completely randomly.

Pair Corralation between Novo Nordisk and CSL

Assuming the 90 days trading horizon Novo Nordisk AS is expected to generate 1.67 times more return on investment than CSL. However, Novo Nordisk is 1.67 times more volatile than CSL LTD SPONADR. It trades about 0.06 of its potential returns per unit of risk. CSL LTD SPONADR is currently generating about 0.06 per unit of risk. If you would invest  5,170  in Novo Nordisk AS on April 20, 2025 and sell it today you would earn a total of  390.00  from holding Novo Nordisk AS or generate 7.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  CSL LTD SPONADR

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novo Nordisk AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Novo Nordisk may actually be approaching a critical reversion point that can send shares even higher in August 2025.
CSL LTD SPONADR 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CSL LTD SPONADR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward-looking indicators, CSL is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Novo Nordisk and CSL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and CSL

The main advantage of trading using opposite Novo Nordisk and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.
The idea behind Novo Nordisk AS and CSL LTD SPONADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios